Skip to contentB
Bio-Path Holdings, Inc.
B
BPTHBio-Path Holdings, Inc. Q3 2019 · 10-Q
Revenue—
Net Income-$2.24M-$2.24MN/M vs Q3 2018 EPS Diluted-$0.78-$0.78N/M vs Q3 2018 Operating Income-$2,271,000N/M Operating Cash Flowderived-$1,893,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Path Holdings, Inc. · CIK 1133818 · Engraved from SEC EDGAR
Free Cash Flowderived-$1,893,000N/M ended Sep 30, 2019 · filed Nov 14, 2019 · 45 d after period end